• November 17, 2014

    Bryan Downey Joins Company as President

    Downey, BryanNovember 17, 2014 — Jubilant HollisterStier announces the appointment of Bryan Downey as President of its allergy company, HollisterStier Allergy.

    Mr. Downey has had a long and successful career at Sanofi, most recently as Vice President & Head, Cardiovascular and Allergy, of the company’s U.S. operations. While there, he oversaw the launch of the first epinephrine auto-injector with instructional voice prompts. He has worked across various sectors and therapeutic areas including serving as the Vice President & General Manager in Puerto Rico, charged with positioning the internal portfolio for growth. Prior to that, Bryan served in Sales, Marketing and Finance roles of increasing responsibility.

    Mr. Downey and his family will be relocating to Spokane, WA from New Jersey.

  • October 3, 2014

    We’ll be at ACAAI in Atlanta

    Come visit us, we’ll be in booth 701. [read more]

  • September 29, 2014

    Order Information During Fall Plant Maintenance

    At Jubilant HollisterStier we temporarily halt production each spring and fall to make major investments in equipment and plant facilities. During this time we also conduct training for production, quality, and leadership personnel. These actions ensure that we have the best trained team working in a state of the art facility.

    This fall’s shutdown is expected to last from October 6 to October 20. What does this mean to you?

    1. There should be minimal delays supplying stocked products during this time.

    2. Orders which can be filled will be processed as quickly as possible during the week of October 20.

    If you have any questions about this biannual event or would like more information on your order, contact your sales representative or our customer service center at 800-992-1120.

  • May 6, 2014

    Update on Ordering Information During Spring Maintenance

    Every spring and fall at Jubilant HollisterStier, we temporarily halt production to make major investments in equipment and plant facilities. We also conduct training for production, quality, and leadership personnel. These actions ensure that we have the best trained team working in a state of the art facility. This spring’s shutdown on April 6 expected to find us back online the week of April 19. We have chosen to extend this and we anticipate resuming production the week of May 19.

    What does this mean to you?

    1. There should be minimal delays supplying stocked products during this time because inventory of stocked products was increased prior to April 6.

    2. Orders will be filled as quickly as possible during the week of May 19.

    If you would like a more specific idea of when your order will be filled, contact your sales representative or our customer service center at 800-992-1120.

    Why have we opted for this delay?

    We have chosen to make a greater investment in our facility than originally planned. We will be updating facility infrastructure and equipment, reviewing many procedures, and doing even more training. When we resume production, we will have delivered our facility and personnel to a position of the highest quality standards attainable.

  • March 26, 2014

    Ordering Information During April Maintenance

    Dear Allergy Treatment Specialist,

    HollisterStier Allergy is currently preparing for our twice yearly maintenance activities, which include upgrades to the facility equipment and systems. The first day being off-line for planned improvements this spring will be April 6, 2014. All renovation and maintenance activities should be completed by April 19 allowing production to resume the week of April 21, 2014.

    While the interruption to manufacturing may appear on the surface to be merely an inconvenience, it is truly a reflection of our commitment to quality and process improvements. Scheduling time in both the spring and fall to take on projects allows us to plan beneficial changes with no worry of unexpected developments that could potentially disrupt your product deliveries and treatment schedules.

    To further ensure you don’t experience disruption in your service, we plan to increase inventory of stocked products prior to April 7; stock orders will continue to ship during maintenance.

    We would like to help you plan your orders in anticipation of this scheduled downtime. If you would like to review your product needs, contact your sales professional or our customer service center for assistance: call 800-992-1120 or email customerservice@jhs.jubl.com.

    The HollisterStier Allergy team thanks you for your patience as we implement improvements, and get back to business as usual.

    Thank you for your understanding,

    Kevin Garrity
    President, HollisterStier Allergy

  • February 7, 2014

    Come See Us at The AAAAI Annual Meeting in San Diego

    The 2014 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting is just around the corner. Please join us in San Diego, California from February 28 to March 4. Stop by booth 215 to talk with our team. We hope you are able to attend. Attendees will have the opportunity to take part in the educational sessions for allergy and immunology professionals, enjoy social and networking events, and explore the exhibit booths showcasing products specifically suited to allergy practices. Please stop by the HollisterStier Allergy booth while you are enjoying the meeting.

  • January 9, 2014

    ABS and NSP Update from our President

    Dear Valued Customers,

    The HollisterStier Allergy team has spent more than four months analyzing the instances of glass delamination that compelled us to voluntarily recall our 2mL, 5mL, and 10mL vials of ABS and NSP in July. Our investigation revealed the glass tubing vials, used to package our product, were the most probable cause of the glass attack. In order to assess the probability of glass delamination, we have conducted tests on vials produced by two major glass suppliers in the US market. While both vendors must adhere to standards set for all Type 1 clear, USP/EP vials, there is still some room for variation in the finished vials based on the speed and temperature of production and the annealing process during manufacturing. After reviewing all of our results we have chosen to move forward using the glass tubing vials that stood up the best according to testing in our labs. We plan to continue to evaluate glass vials from other manufacturers for their potential, and for future use. Based on our understanding of the mechanics of the glass delamination and our evaluations of the vials, we are beginning production of the 5mL and 10mL vials using glass tubing vials purchased from the vendor designated by our testing procedures.

    After performing accelerated testing on the glass vials, analyzing the test results, and reviewing the data collected from our stability testing, we have chosen to decrease the dating on our diluents packaged in glass tubing vials. We feel it is our obligation to reduce our dating from 36 months to 18 months. While this reduction in shelf-life may be viewed as overly cautious by some in our industry, we feel it is the best measure we can take to maintain product safety for you and your patients. We will continue to evaluate other vial options with the intent to maintain safety while extending dating on the diluent products. We will be able to continue to offer 36 month dating on the 30mL and 100mL diluents filled in our molded glass vials.

    HollisterStier Allergy is currently resuming manufacturing of diluent packaged in 5mL vials. It will take some time to receive vial volumes sufficient enough to manufacturer our 10mL diluent product line, so the 10mL vials of diluents are expected to take longer to bring back into production. Our goal is to have our 5 mL ABS and NSP in all of the colored vial presentations available to customers starting in January.

    If you have questions or would like more information, please feel free to contact our technical services department or your sales representative at anytime. Thank you for your understanding as we move forward with this new solution.

    Best regards,

    Kevin Garrity